Procurement Summary
Country: Germany
Summary: Framework Agreement for in Vivo Studies on Nb-Pdx Models in Mice
Deadline: 23 Oct 2026
Posting Date: 24 Sep 2026
Other Information
Notice Type: Tender
TOT Ref.No.: 149744373
Document Ref. No.: 657693-2026
Competition: ICB
Financier: Self Financed
Purchaser Ownership: Public
Tender Value: Refer Document
CPV Classification
73111000 - Research laboratory services
73110000 - Research services
Purchaser's Detail
Name: Login to see tender_details
Address: Login to see tender_details
Email: Login to see tender_detailsLogin to see details
Tender Details
Framework agreement for in vivo studies on NB-PDX models in mice
The Charite - Universitatsmedizin Berlin, Chariteplatz 1, 10117 Berlin is writing a framework agreement for the implementation of in-vivo studies (therapy, characterization or biodistribution/pharmacokinetics studies) on patient-derived Neuroblastoma xenograft models in mice ("NB-PDX models") and removal of PDX tumor material. This is a framework agreement with only one contractor.
There are special requirements according to the Berlin Tendering and Procurement Act (BerlAVG), see tender documents.
More details Information can be found in the documents provided on the Charite procurement platform (https://vergabeplattform.charite.de).
Doc Title: Framework agreement for in vivo studies on NB-PDX models in mice
Contract type: services
Document Type: Contract Notice
Reference Number: AL 106/26
Contract Type: services
Authority Type: body-pl-ra
Doc Title: Framework agreement for in vivo studies on NB-PDX models in mice
Dispatch Date: 2026-09-22
Publish Date: 2026-09-24
Submission Date: 2026-10-23
Documents
Tender Notice